Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors

Despite advances in systemic therapies for solid tumors, the development of brain metastases remains a significant contributor to overall cancer mortality and requires improved methods for diagnosing and treating these lesions. Similarly, the prognosis for malignant primary brain tumors remains poor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Neurol
Auteurs principaux: Ramkissoon, Lori A., Pegram, Worthy, Haberberger, James, Danziger, Natalie, Lesser, Glenn, Strowd, Roy, Dahiya, Sonika, Cummings, Thomas J., Bi, Wenya Linda, Abedalthagafi, Malak, Sathyan, Pratheesh, McGregor, Kimberly, Reddy, Prasanth, Severson, Eric, Williams, Erik, Lin, Douglas, Edgerly, Claire, Huang, Richard S. P., Hemmerich, Amanda, Creeden, James, Brown, Charlotte, Venstrom, Jeffrey, Hegde, Priti, Ross, Jeffrey S., Alexander, Brian M., Elvin, Julia, Ramkissoon, Shakti H.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Neurology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604477/
https://ncbi.nlm.nih.gov/pubmed/33192972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.544680
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires